Cyclacel Pharma- Hostile buyout could

Discussion in 'Industry Rumors' started by Anonymous, Feb 27, 2015 at 12:45 PM.

Tags: Add Tags
  1. #1 Anonymous, Feb 27, 2015 at 12:45 PM
    Anonymous

    Anonymous Guest

    Could see considering how undervalued it is here
     
    Quote

  2. #2 Anonymous, Feb 27, 2015 at 3:05 PM
    Anonymous

    Anonymous Guest

    Rumors floating around- Novartis and Cyclacel
     
    Quote
  3. #3 Anonymous, Mar 1, 2015 at 12:19 PM
    Anonymous

    Anonymous Guest

    Either Novartis it Johnson and Johnson. They're in the product like now so would face direct competition. Given their market cap which is absolutely nothing considering their cash on hand, we may soon see something come to fruition here.
     
    Quote
  4. #4 Anonymous, Mar 1, 2015 at 8:56 PM
    Anonymous

    Anonymous Guest

    AstraZeneca
     
    Quote
  5. #5 Anonymous, Mar 2, 2015 at 5:15 AM
    Anonymous

    Anonymous Guest

    Undervalued is an outright understatement givens its stage and cash book value. If it wasn't for its CEO - Spiros, this would have been $5+
     
    Quote
  6. #6 Anonymous, Mar 2, 2015 at 6:58 AM
    Anonymous

    Anonymous Guest

    Bout time he hands this to some capable hands
     
    Quote
  7. #7 Anonymous, Mar 2, 2015 at 7:57 AM
    Anonymous

    Anonymous Guest

    Well said, thus guy needs to let go and let a large Pharma run with this science
     
    Quote
Reply to Thread